ClinicalTrials.gg
RecruitingNCT07598149GLOWUpdated Nov 5, 2026

Glucose Levels and Outcomes in Women - Mid Pregnancy

An observational study in Pregnancy, sponsored by Sanford Health. Recruiting at 3 sites in United States. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-05.

Sponsored by Sanford Health · Observational

How we know

From the registry’s dates

  • Started Jun 2026; still recruiting 4 months later.
Updated Nov 5, 2026Now RecruitingSite recruiting status changed+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
50
Ages
18 Years and older
Sex
Female
01

Study summary

Up to 75% of reproductive age women are overweight, 40% are considered obese, and the prevalence of gestational diabetes mellitus (GDM) continues to rise, from 6% to 8.3% between 2016 and 2021. Currently understood GDM risk factors, such as advanced maternal age, prior history of GDM, family history of diabetes, and socioeconomic status can only explain up to 50% of cases. Related factors such as body image dissatisfaction, eating behaviors, and daily stress exposure have been linked to blood sugar metabolization, pregnancy outcomes, and the normative physiological changes that occur during pregnancy. These interrelated mechanisms may serve as additional risk factors that could help identify other women at risk of GDM. This project aims to investigate how body image dissatisfaction, eating behaviors, and daily stress exposure are associated with the metabolization of blood sugar during pregnancy.

In this study the Strahm Lab will recruit 50 pregnant women to participate in a study assessing blood sugar metabolization as it is related to stress, body image dissatisfaction, and eating behaviors. The study will use continuous glucose monitoring in concert with an ecological momentary assessment protocol to assess these interrelated factors over the course of 10 days between 14 and 28 weeks gestation.

02

Conditions studied

  • Pregnancy

Keywords

  • pregnancy
  • blood sugar
  • stress
  • body image
03

In context

Lead sponsor

Sanford Health is the lead sponsor of 40 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The investigators will recruit 50 pregnant women prior to their 28th week of gestation from Sanford Health prenatal care providers in the Sioux Falls, SD, and Fargo, ND, areas.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • At least 18 years old
  • Healthy single baby pregnancy
  • 14 to 28 weeks of pregnancy

Exclusion criteria

Exclusion Criteria:

  • history of diabetes
  • history of gestational diabetes mellitus (GDM)
  • history of cardiac disease
  • history of endocrine disease
  • assistive reproductive technology (IVF)
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
50 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Continuous Blood Glucose via Dexcom G7

    Participant will wear a Dexcom G7 CGM for 10 days to measure blood glucose levels (mg/dL)

    Time frame: 10 days

  2. Body Image in Pregnancy Scale (BIPS)

    Participants will complete the full Body Image in Pregnancy Scale (BIPS) once prior to the start of the 10 day CGM/momentary assessment period and once at the end. The full BIPS scale is 36 items. It assesses body image dissatisfaction. Participants rate each item from one (strongly disagree) to five (strongly agree). Generally, lower scores indicate higher body satisfaction, while higher scores indicate higher levels of pregnancy-related body dissatisfaction/stress due to body image. Participants will receive 8 items from the scale to assess preoccupation with physical appearance and sexual attractiveness, prioritization of physical appearance over body functioning, appearance related behavioral avoidance, and dissatisfaction with body parts at least 5 times each day during the 10 day CGM/momentary assessment period. The full BIPS will be completed in REDCap. Momentary assessments will be completed via Real Time Assessment In the Natural Environment (ReTAINE).

    Time frame: 10 days

07

Study locations

3 of 3 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Started Jun 2026 (actual). Primary completion is estimated for May 2027, 11 months after the start.

Start moved once since we started tracking on Sep 25, 2026: May 2026 → Jun 2026, on Nov 5, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
May 11, 2026
First posted
May 20, 2026
StartActual
Jun 25, 2026was May 2026
Primary completionEst.
May 2027
CompletionEst.
May 2028
Last update
Nov 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Nov 5, 2026
Sites
3 sites changed recruiting status (3 now recruiting)
Show 3 sites
  • North Dakota State University · Fargo, United Statesno status→Recruiting
  • Sanford Health · Fargo, United Statesno status→Recruiting
  • Sanford Health · Sioux Falls, United Statesno status→Recruiting
Nov 5, 2026
Start date
May 2026→Jun 25, 2026 (actual)
Nov 5, 2026
Show all 1 update
  1. Nov 5, 2026
    Not yet recruiting→Recruiting
    3 sites changed recruiting status (3 now recruiting)
    Show 3 sites
    • North Dakota State University · Fargo, United Statesno status→Recruiting
    • Sanford Health · Fargo, United Statesno status→Recruiting
    • Sanford Health · Sioux Falls, United Statesno status→Recruiting
    Start date May 2026→Jun 25, 2026 (now actual)

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07598149
Lead sponsor
Sanford Health
Collaborators
North Dakota State University
Responsible party
Sponsor
First posted
May 20, 2026
Start date
Jun 25, 2026
Primary completion
May 2027 (estimated)
Completion
May 2028 (estimated)
Last update
Nov 5, 2026

Study contacts

Grace Biermann, MPH
Contact
strahmlab@sanfordhealth.org
605-312-6457
Anna M. Strahm, PhD
principal investigator · Sanford Health

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion